We are live on ! Find out more
UBS AM

UBS AM Portfolio holdings

AUM $481B
1-Year Est. Return 26.39%
 

UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.

This Fund
S&P 500
This Quarter Est. Return
+2.96%
1 Year Est. Return
+26.39%
3 Year Est. Return
+93.76%
5 Year Est. Return
+124.47%
10 Year Est. Return
+503.87%
AUM
$88.5B
AUM Growth
+$2.22B
Cap. Flow
-$721M
Cap. Flow %
-0.82%
Top 10 Hldgs %
14.33%
Holding
2,695
New
65
Increased
1,198
Reduced
577
Closed
89

Top Buys

Rank Stock Value
1
SPGI icon
S&P Global
SPGI
+$205M
2
JNJ icon
Johnson & Johnson
JNJ
+$186M
3
HON icon
Honeywell
HON
+$177M
4
MDLZ icon
Mondelez International
MDLZ
+$132M
5
BABA icon
Alibaba
BABA
+$130M

Sector Composition

Rank Sector Weight
1 Healthcare 15.89%
2 Technology 14.47%
3 Financials 12.9%
4 Consumer Discretionary 10.06%
5 Communication Services 8.98%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CLNE icon
2426
Clean Energy Fuels
CLNE
$418M
$171K ﹤0.01%
49,151
EXTR icon
2427
Extreme Networks
EXTR
$4.12B
$171K ﹤0.01%
50,541
ERII icon
2428
Energy Recovery
ERII
$460M
$170K ﹤0.01%
+19,100
New +$204K
SGMO
2429
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$170K ﹤0.01%
29,398
CLVS
2430
DELISTED
Clovis Oncology, Inc.
CLVS
$169K ﹤0.01%
12,289
SGYP
2431
DELISTED
Synergy Pharmaceuticals, Inc Common Stock
SGYP
$169K ﹤0.01%
44,400
XCO
2432
DELISTED
Exco Resources
XCO
$169K ﹤0.01%
8,638
+2,200
+34% +$38.2K
TPCO
2433
DELISTED
Tribune Publishing Company Common Stock
TPCO
$168K ﹤0.01%
12,181
ICON
2434
DELISTED
Iconix Brand Group, Inc.
ICON
$168K ﹤0.01%
2,480
AMRI
2435
DELISTED
Albany Molecular Research Inc
AMRI
$168K ﹤0.01%
12,500
PDFS icon
2436
PDF Solutions
PDFS
$2.13B
$166K ﹤0.01%
11,900
TACO
2437
DELISTED
Del Taco Restaurants, Inc. Common Stock
TACO
$166K ﹤0.01%
18,200
COHU icon
2438
Cohu
COHU
$2.42B
$165K ﹤0.01%
15,241
TROX icon
2439
Tronox
TROX
$919M
$165K ﹤0.01%
37,498
TLGT
2440
DELISTED
Teligent, Inc
TLGT
$165K ﹤0.01%
2,310
PPP
2441
DELISTED
Primero Mining Corp
PPP
$165K ﹤0.01%
79,796
BZH icon
2442
Beazer Homes USA
BZH
$904M
$164K ﹤0.01%
21,099
MNKD icon
2443
MannKind Corp
MNKD
$1.17B
$164K ﹤0.01%
28,349
KBAL
2444
DELISTED
Kimball International
KBAL
$164K ﹤0.01%
14,398
WW
2445
DELISTED
WW International
WW
$162K ﹤0.01%
13,899
IXYS
2446
DELISTED
IXYS Corp
IXYS
$162K ﹤0.01%
15,829
ALJ
2447
DELISTED
Alon USA Energy Inc
ALJ
$161K ﹤0.01%
24,799
VICR icon
2448
Vicor
VICR
$10.6B
$160K ﹤0.01%
15,900
MTUS icon
2449
Metallus
MTUS
$850M
$160K ﹤0.01%
16,648
CAFD
2450
DELISTED
8point3 Energy Partners LP
CAFD
$160K ﹤0.01%
10,100

Similar funds

UBS AM's Q2 2016 Portfolio in Review

As of Q2 2016, UBS AM held 2,695 positions worth $88.5B, up 2.6% from $86.2B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

UBS AM's Q2 2016 filing shows 65 new, 1,198 increased, 577 reduced and 89 closed positions. Its largest new stake was S&P Global: 1,914,020 shares worth $205M. The largest sale was MCGRAW-HILL FINANCIAL INC COM, an estimated $270M.

By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 15% a quarter earlier, followed by Technology and Financials.

  • UBS AM's largest Q2 2016 buy was S&P Global: 1,914,020 shares worth $205M.
  • UBS AM added most to Johnson & Johnson in Q2 2016, an estimated $186M increase.
  • UBS AM's biggest Q2 2016 reduction was Citigroup, cutting an estimated $185M.
  • UBS AM fully exited MCGRAW-HILL FINANCIAL INC COM in Q2 2016, selling an estimated $270M.
  • UBS AM's ten largest holdings make up 14% of its $88.5B portfolio in Q2 2016.
  • UBS AM opened 65 new positions and closed 89 in Q2 2016.
  • UBS AM's portfolio value rose 2.6% quarter-over-quarter to $88.5B.

Based on UBS AM's 13F filing for Q2 2016, filed 9 Aug 2016.